Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN17079225) titled 'Helping Albertans with diabetes: a pharmacist-led care program in community pharmacies' on Oct. 6.
Study Type: Interventional
Study Design:
Multicenter interventional randomized controlled trial (Treatment)
Primary Sponsor: University of Alberta
Condition:
Type 2 diabetes
Nutritional, Metabolic, Endocrine
Intervention:
Participants in the intervention arm will receive the care using a shared decision-making pharmacist care pathway approach designed to guide type 2 diabetes management to achieve target A1C levels and reduce the risk of diabetes-related complications. The pharmacist care pathway is modelled a...